Evidence map›Paper›PMID 24829852›Full record

ReviewWorld journal of clinical oncology2014

Magnetic resonance imaging in breast cancer: A literature review and future perspectives.

Gisela Lg Menezes, Floor M Knuttel, Bertine L Stehouwer, Ruud M Pijnappel, Maurice Aaj van den Bosch

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of clinical oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 4 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 4 syntheses or guidelines pooled it, 179 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Monitoring Pharmacological Treatment of Breast Cancer with MRI.Current issues in molecular biology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gisela Lg MenezesGisela LG Menezes, Floor M Knuttel, Bertine L Stehouwer, Ruud M Pijnappel, Maurice AAJ van den Bosch, Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, 3508 GA Utrecht, The Netherlands.
Floor M KnuttelGisela LG Menezes, Floor M Knuttel, Bertine L Stehouwer, Ruud M Pijnappel, Maurice AAJ van den Bosch, Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, 3508 GA Utrecht, The Netherlands.
Bertine L StehouwerGisela LG Menezes, Floor M Knuttel, Bertine L Stehouwer, Ruud M Pijnappel, Maurice AAJ van den Bosch, Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, 3508 GA Utrecht, The Netherlands.
Ruud M PijnappelGisela LG Menezes, Floor M Knuttel, Bertine L Stehouwer, Ruud M Pijnappel, Maurice AAJ van den Bosch, Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, 3508 GA Utrecht, The Netherlands.
Maurice Aaj van den BoschGisela LG Menezes, Floor M Knuttel, Bertine L Stehouwer, Ruud M Pijnappel, Maurice AAJ van den Bosch, Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, 3508 GA Utrecht, The Netherlands.
Utrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early detection and diagnosis of breast cancer are essential for successful treatment. Currently mammography and ultrasound are the basic imaging techniques for the detection and localization of breast tumors. The low sensitivity and specificity of these imaging tools resulted in a demand for new imaging modalities and breast magnetic resonance imaging (MRI) has become increasingly important in the detection and delineation of breast cancer in daily practice. However, the clinical benefits of the use of pre-operative MRI in women with newly diagnosed breast cancer is still a matter of debate. The main additional diagnostic value of MRI relies on specific situations such as detecting multifocal, multicentric or contralateral disease unrecognized on conventional assessment (particularly in patients diagnosed with invasive lobular carcinoma), assessing the response to neoadjuvant chemotherapy, detection of cancer in dense breast tissue, recognition of an occult primary breast cancer in patients presenting with cancer metastasis in axillary lymph nodes, among others. Nevertheless, the development of new MRI technologies such as diffusion-weighted imaging, proton spectroscopy and higher field strength 7.0 T imaging offer a new perspective in providing additional information in breast abnormalities. We conducted an expert literature review on the value of breast MRI in diagnosing and staging breast cancer, as well as the future potentials of new MRI technologies.

Indexed as

7.0 TeslaBreast magnetic resonance imagingCancerDiffusion-weighted imagingSpectroscopy

Identifiers

PMID24829852
PMCPMC4014797
OpenAlexW2038335084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.